tiprankstipranks
Trending News
More News >
OnKure Therapeutics (OKUR)
NASDAQ:OKUR
US Market

OnKure Therapeutics (OKUR) Income Statement

Compare
408 Followers

OnKure Therapeutics Income Statement

Last quarter (Q3 2025), OnKure Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, OnKure Therapeutics's net income was $-14.70M. See OnKure Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -50.00K$ -37.00K
Operating Expenses
$ 54.39M$ 36.93M$ 29.77M$ 39.77M$ 19.52M
Depreciation and Amortization
$ 662.00K$ 560.00K$ 387.00K$ 50.00K$ 37.00K
EBITDA
$ -51.71M$ -34.75M$ -29.38M$ -39.72M$ -19.43M
Operating Income
$ -54.39M$ -36.93M$ -29.77M$ -39.82M$ -19.55M
Other Income/Expenses
$ 1.71M$ 1.62M$ 254.00K$ 48.00K$ 87.00K
Pretax Income
$ -52.67M$ -35.31M$ -29.51M$ -39.77M$ -19.46M
Net Income
$ -52.67M$ -35.31M$ -29.51M$ -39.77M$ -19.46M
Per Share Metrics
Basic EPS
$ -3.95$ -2.65$ -2.21$ -21.92$ -7.74
Diluted EPS
$ -3.95$ -2.65$ -2.21$ -21.92$ -7.74
Weighted Average Shares Outstanding
13.34M 13.34M 13.34M 1.81M 2.51M
Weighted Average Shares Outstanding (Diluted)
13.34M 13.34M 13.34M 1.81M 2.51M
Currency in USD

OnKure Therapeutics Earnings and Revenue History